Physician profile
Nirav R Sheth
NPI 1770579369
$778.26
in general payments reported to CMS, 2019-2025
10 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.55 · 2022: $56.59 · 2023: $508 · 2024: $62.05 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $174.98 | 2023-2024 | |
| Impulse Dynamics (USA) INC. | $169.98 | 2023 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $160.23 | 2023-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $69.26 | 2020-2023 | Cardiomems |
| Nestle Healthcare Nutrition INC. | $57.17 | 2022-2023 | |
| Siemens Medical Solutions USA, INC. | $51.23 | 2023-2025 | Acuson Origin Diagnostic Ultrasound System |
| Lexicon Pharmaceuticals, INC. | $30.59 | 2023 | Inpefa |
| Amgen INC. | $30.09 | 2023 | Repatha |
| Kiniksa Pharmaceuticals, LTD. | $20.84 | 2023 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.